{"groups":[{"description":"Melphalan flufenamide (melflufen) 40 mg Day 1 and dexamethasone 40 mg (reduced dose for patients 75 years or older) on Days 1, 8, 15 and 22 of each 28-day cycle.\n\nMelphalan flufenamide (Melflufen)\n\nDexamethasone","id":"FG000","title":"Melphalan Flufenamide (Melflufen) + Dexamethasone: Full Analysis Set"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"157"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"157"}],"comment":"Study completion for assessment of endpoints","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"157 Patients were enrolled and treated on study"}